# FDA Inspection 1324326 - Boiron Inc. - June 26, 2026

Source: https://www.keypedia.com/records/fda_inspections/boiron-inc/ae45dc26-27c6-46bd-afac-9e2480c2c93f
Source feed: FDA_Inspections

> FDA Inspection 1324326 for Boiron Inc. on June 26, 2026. Classification: N/A.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1324326
- Company Name: Boiron Inc.
- Inspection Date: 2026-06-26
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Office Name: Philadelphia District Office

## Related Documents

- [FDA Inspection 1155509 - 2021-10-25](https://www.keypedia.com/records/fda_inspections/boiron-inc/2188dede-62b5-4eb4-9df0-73f9607ca7a0)
- [FDA Inspection 1007059 - 2017-02-14](https://www.keypedia.com/records/fda_inspections/boiron-inc/3f065653-6118-4f80-b305-20852cc18b91)
- [FDA Inspection 716890 - 2011-03-18](https://www.keypedia.com/records/fda_inspections/boiron-inc/676e53ae-3723-4ade-bf22-50084bda0a67)

Company: https://www.keypedia.com/companies/boiron-inc/502403cd-f15f-4cf9-8bc2-70e99a8749b4

Office: https://www.keypedia.com/offices/philadelphia-district-office/c5ec7398-b3d5-4125-9793-fb7b972578d8